Marker Therapeutics Inc (MRKR)

[BluMarlin1960]

TomP1, since you seem to have an in to Glynn, and he responds to your emails, could you possibly cut and paste the url Dyp just provided #21126 [press release] and send an email to Glynn, asking him to explain and how it affects Tapimmune's trials neagatively or not.

RK would be also a great one to ask, as I am not a scientist and do not know the particulars in how certain trials interact with one another.

Is that possible?, any feedback would be most welcome by everyone on this board I am sure.

Either way I would still believe that because TPIVs cost to produce/manufacture would still be a much sought after vaccine, even if they are not first to market.

Thanks in advance, and thank you for your input over the years.

BLU